Non-melanoma skin cancers, in particular keratoacanthomas (KAs) and squamous cell carcinomas (SCCs), have become highly frequent tumor types especially in immunesuppressed transplant patients. Nevertheless, little is known about essential genetic changes. As a paradigm of 'early' changes, that is, changes still compatible with tumor regression, we studied KAs by comparative genomic hybridization and show that gain of chromosome 11q is not only one of the most frequent aberration (8/18), but in four tumors also the only aberration. Furthermore, 11q gain correlated with amplification of the cyclin D1 locus (10/14), as determined by fluorescence in situ hybridization, and overexpression of cyclin D1 protein (25/31), as detected by immunohistochemistry. For unraveling the functional consequence, we overexpressed cyclin D1 in HaCaT skin keratinocytes. These cells only gained little growth advantage in conventional and in organotypic cocultures. However, although the control vector-transfected cells formed a well-stratified and orderly differentiated epidermis-like epithelium, they showed deregulation of tissue architecture with an altered localization of proliferation and impaired differentiation. The most severe phenotype was seen in a clone that additionally upregulated cdk4 and p21. These cells lacked terminal differentiation, exhibited a more autonomous growth in vitro and in vivo and even formed tumors in two injection sites with a growth pattern resembling that of human KAs. Thus, our results identify 11q13 gain/cyclin D1 overexpression as an important step in KA formation and point to a function that exceeds its known role in proliferation by disrupting tissue organization and thereby allowing abnormal growth.
Introduction
Non-melanoma skin cancer is the most frequent tumor type worldwide and the number is still increasing (Euvrard et al., 2003) . In organ transplant patients in particular, both the malignant skin squamous cell carcinoma (SCC) and the benign keratoacanthoma (KA) develop frequently in sun-exposed areas within the first 5-10 years of immunosuppression. These patients often suffer from second or even multiple lesions, and the SCCs become life threatening as they tend to grow more rapidly, show a higher rate of local recurrences and metastasize in 5-8% of the patients (all reviewed in Freedberg et al., 1999) . Nevertheless, knowledge about causal genetic aberrations and understanding of functional consequences of such aberrations in the development and/or progression of non-melanoma skin cancer is still poor.
Skin SCC development is viewed as a multistep process with cumulative lifetime exposure of UV radiation being the major carcinogen (reviewed in Boukamp, 2005) . Actinic keratoses (AKs) are commonly believed to be precancerous lesions because B10% of the cases will develop into invasive SCCs (Johnson et al., 1992) . The position of the KA in this sequence is still a matter of debate. Keratoacanthomas are characterized by rapid growth for the first 4-8 weeks and spontaneous possibly self-induced regression after 3-6 months. Owing to the initially very similar morphology, KAs strongly resemble well-differentiated SCCs (Billingsley et al., 1999) . Because of their ability to spontaneously regress, KAs must have acquired genetic aberrations that, while promoting tumor growth, are still compatible with tumor reversion. Thus, identifying their aberration profile may lead to a better understanding of the early skin cancer development, and may help to define potential targets for premetastatic interference treatment in SCC of the skin.
An early and most likely initiating event is mutational inactivation of the p53 tumor suppressor gene (for review see Boukamp, 2005) . p53 mutations have been found in otherwise unsuspicious epidermis (Nakazawa et al., 1994; Jonason et al., 1996; Ling et al., 2001) and in many of p53 patches detected by immunohistochemistry underlying mutation could also be demonstrated (Jonason et al., 1996; Ren et al., 1996) . Furthermore, Rees and co-workers (Quinn et al., 1994) reported on loss of heterozygozity (LOH) of 9p markers in SCC as well as markers in a number of other chromosomes such as 3p, 13p, 17p and 17q . In Aks, they found LOH of many of the same loci as in SCCs, whereas in KAs, the frequency of LOH was low with only isolated losses at 9p, 9q and 10q Waring et al., 1996) . From this, it was suggested that KAs are not SCCs that are still able to regress but are different de novo. Loss of heterozygozity studies, however, only detect loss of chromosomal material, that is, loss of potential tumor suppressor genes. Gain and with that potential oncogenic activation will only be seen by cytogenetic analyses including comparative genomic hybridization (CGH), a technique allowing genome-wide screening for chromosomal gains and losses (Kallioniemi et al., 1992) . One CGH study was previously applied on KAs, demonstrating a high frequency of tumors without genetic alterations (about 65%) and only low frequency of recurrent alterations, for example, gain of 8q and loss of 3p, 9p or 19p in 20% of the tumors (Clausen et al., 2002) . As these changes were, however, also among those characteristically seen in SCCs (Jin et al., 1999; Popp et al., 2000 Popp et al., , 2002 Jin et al., 2002; Ashton et al., 2003) , KAs and SCCs likely share a common developmental history and it is reasonable to propose that increasing our knowledge on the genetics of KAs is an important step in elucidating the crucial changes involved in the initiation of skin cancer.
Using CGH we now show that gain of 11q is one of the most frequent aberrations in KAs. This gain correlates with amplification of the cyclin D1 locus, mapped to 11q13. Interestingly, we see amplification of the cyclin D1 locus by in situ detection in tumors that do not show 11q gain by CGH, thus suggesting that duplication of larger chromosomal regions and amplification of very small chromosomal areas are characteristic for KAs. In these as well as tumors with no cytogenetic evidence for changes in chromosome 11q13, we find overexpression of cyclin D1 protein pointing to an additional level of deregulation of the cyclin D1 gene in these tumors. Furthermore, by overexpressing cyclin D1 in the spontaneously immortalized HaCaT skin keratinocytes, we provide evidence for its functional role in proliferation as well as -and most importantly -in disturbing tissue organization.
Results
Comparative genomic hybridization identifies gain of chromosome 11q as the most frequent aberration in keratoacanthoma In order to identify candidate genes that contribute to skin cancer development, we applied CGH on 24 KAs. In six cases (25%), no aberrations were detected, whereas the remaining 18 KAs (75%) carried changes in single chromosomes or showed highly complex aberration patterns (Table 1) . Nevertheless, there was a clear prevalence for two aberrations: gain of one entire chromosome 17 (7/18) or its long arm (2/18) and gain of parts of chromosome 11 (8/18), all but one containing the region of 11q13. Whereas gain of chromosome 17 was particularly frequent in KAs originating from the same patient (7/8 multiple KAs) and thus argued for a patient-specific aberration, 11q gain was frequent in the KAs derived from different individuals (6/10 sporadic KAs). Intriguingly, in four of them, 11q gain was the only aberration detectable by CGH.
Gain of 11q is correlated with amplification of the cyclin D1 gene The high frequency of 11q gain (44%) together with our previous finding that most of our skin SCC lines showed 11q gain with the smallest common region of 11q13 (Popp et al., 2002) prompted us to concentrate on chromosome 11q. Furthermore, we previously showed that tumorigenic conversion of our experimental skin carcinogenesis model, the HaCaT keratinocytes, similarly correlated with 11q13 gain and this gain was in turn correlated with a high level of cyclin D1 expression (Boukamp et al., 1999) . Thus, despite a number of interesting genes located on 11q13, cyclin D1 was selected as the most promising candidate.
To study amplification of cyclin D1 locus in more detail, we analysed sections from 14 KAs by fluorescence in situ hybridization (FISH) with a cyclin D1-specific DNA probe. In order to omit polyploidy and incomplete nuclei in the tissue sections, the KAs were The bold values are to highlight the chromosome 11 aberration as the major aberration.
Cyclin D1 overexpression in keratoacanthoma B Burnworth et al co-hybridized with a chromosome 11-specific centromere probe and only nuclei with two centromeric signals were quantified. Ten of the 14 (71%) KAs showed gain of cyclin D1 gene copy numbers with an average of at least three copies per nuclei leading to a ratio >1 (Figure 1a , upper part). Examples for low ( Figure 1a , middle part) and high amplification of the cyclin D1 locus (Figure 1a , lower part) are presented in Figure 1a . Three KAs exhibited a normal (1.0) ratio and one KA loss of cyclin D1 signals. Interestingly, among the KAs with increased copy numbers, two were inconspicuous by CGH analysis, exhibiting no obvious gains and losses in any chromosome.
To determine if amplification of the cyclin D1 locus is crucial for skin cancer in general, we also investigated 11 SCCs. From these, six showed amplification with an average of three gene copies per tumor cell nucleus, three exhibited a normal ratio and two displayed loss of cyclin D1 signals ( Figure 1b Cyclin D1 is overexpressed in the majority of nonmelanoma skin tumors We next asked whether amplification of the cyclin D1 locus would also result in increased protein expression and investigated normal skin samples, five AKs, 31 KAs and 17 SCCs by immunohistochemistry. As recent experiments had shown that most specific reactions with the anti-cyclin D1 antibody were obtained with paraffinembedded material, only archival tissue was studied. As exemplified in Figure 2a and b, expression could be detected neither in normal skin nor in AKs. However, 25 of the 31 KAs (80%) were cyclin D1-positive (Table 2) . From these, nine showed nuclear staining in >70% of the tumor cells (Figure 2c and d), 12 in 30-70% ( Figure 2e ) and four in less than 30% (Figure 2f ). Figure 1 Cyclin D1 locus amplification in keratoacanthomas (KAs) and squamous cell carcinomas (SCCs). Fluorescence in situ hybridization analysis of KAs (a) and SCCs (b) using a cyclin D1 locus-specific probe and a probe specific for the centromere of chromosome 11. Only nuclei with two centromeric signals were evaluated. Top panels: quantitative evaluation (ratio between the number of centromeric signals and cyclin D1-specific signals of 14 KAs and 11 SCCs. Lower panels: FISH analysis of a sample with mostly three cyclin D1-specific signals (red) versus two centromere 11 (green) signals (middle), and a sample with a higher number of cyclin D1-specific signals (bottom panels).
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Although the number of positive nuclei varied, no differences were seen concerning staining intensity. Interestingly, most of the KAs with little or no expression represented a group of 'early-stage tumors' as indicated by mainly hyperplastic skin with a thickened stratum corneum.
This and the fact that AKs were negative may thus indicate that cyclin D1 upregulation is not required for improved growth per se but may be essential when keratinocytes expand into rapidly growing tumors. Accordingly, from the additionally analysed 17 SCCs, only two were negative for cyclin D1 expression (see Table 2 ). Nine showed staining in >70% of tumor cells, a moderate expression (30-70% positive nuclei) was seen in five and low expression (o30%) in only one SCC.
Taken together, and summarized in Table 2 , the data show that cyclin D1 expression is low in normal skin and early lesions but overexpressed in skin tumors.
Although this upregulation frequently correlated with gene amplification, some tumors did not show indications for chromosomal abnormalities. Therefore, besides gene amplification, also other regulatory mechanisms are likely to contribute to increased cyclin D1 expression in KAs and SCCs.
Functional consequences of cyclin D1 overexpression
To establish the functional consequences of overexpression of cyclin D1 for the tumor phenotype, we generated stable HaCaT cell lines overexpressing the protein.
HaCaT cells are particularly suited because they exhibit a number of chromosomal aberrations characteristic for skin SCCs but lack gain of 11q, are non-tumorigenic, and still possess the ability to form a normally differentiated epidermis-like epithelium under appropriate conditions (Boukamp et al., 1988 (Boukamp et al., , 1997 Lehman et al., 1993; Schoop et al., 1999; Cerezo et al., 2003) . Figure 2 Cyclin D1 is overexpressed in keratoacanthomas (KAs) and squamous cell carcinomas (SCCs). Formalin-fixed sections were subjected to immunohistochemistry using an antibody visualizing cyclin D1 (brown) and being counterstained with hemalaun (blue). Western blot analyses were performed with protein lysates from 14 cyclin D1-transfected (Hcyclin) and three vector-transfected (Hneo) clones. In addition, we included the parental HaCaT cells as controls with normal cyclin D1 levels and the HaCaT 401C cells as those expressing high levels of cyclin D1 (Boukamp et al., 1999) . In eight of the Hcyclin clones, cyclin D1 was increased, reaching similar levels as the HaCaT 401C cells (data not shown). From these, three clones -6, 13 and 15 -were randomly selected for further analysis, in addition to two Hneo clones. With these clones, we next determined how proliferation would influence the expression. Protein extracts were compared from cells in exponential growth phase (subconfluent) with cells at plateau phase (confluent). As shown in Figure 3 , the cyclin D1 level was very similar under both conditions, being increased about twofold in clones 6 and 13 and about threefold in clone 15 as compared to the Hneo control cells. Thus, the higher level of cyclin D1 did not depend on the growth state of the cells but was constitutive.
Overexpression of cyclin D1 stimulates keratinocyte proliferation in vitro only marginally As cyclin D1 is known to promote progression through the G 1 /S phase of the cell cycle and concomitantly to promote proliferation (for review see Sherr and Roberts, 1999) , the three Hcyclin clones were analysed for a number of growth parameters. First, growth curves were performed. In a pattern resembling that of the parental HaCaT cells (data not shown), the Hneo cells exhibited a lag phase of about 80 h before they slowly but steadily increased in cell number ( Figure 4A ). Whereas clone 15 showed a very similar growth profile, clones 6 and 13 proliferated more rapidly (see Figure 4A ). Proliferation activity was also measured by 5-bromo-2 0 deoxyuridine (BrdU) incorporation 48 h after attachment with a BrdU labeling index defined as the ratio between BrdU-labeled cells and the total cell number ( Figure 4B ). Compared to the control cells, a slight increase was seen for clones 6 and 15, whereas clone 13 showed more significant BrdU incorporation.
Improved growth not only comprises a more rapid proliferation but may also result in more autonomous growth. To test this, we plated the cells at low cell density and measured colony-forming efficiency by counting the number of colonies after 2 weeks ( Figure 4C ). During this time period, Hneo cells formed on average 40 colonies. A similar colony number was seen for the Hcyclin clones 6 and 15. Only clone 13 cells showed increased growth rate with an average of 66 colonies. Also the distribution of clone size was rather uniform with mostly small colonies (o2-4 mm), whereas large colonies (>8 mm) were only present in cultures from Hneo and clone 6 cells.
Cyclin D1 overexpression alters the proliferation and differentiation behavior of HaCaT cells in organotypic co-cultures As cyclin D1 overexpression obviously provided some growth advantage in vitro, we next asked whether this would also be of consequence for in vivo growth. To test this, we performed organotypic co-culture (OTC) with the two Hneo clones and the three Hcyclin clones and analysed them in at least two independent experiments. Growing on a collagen gel with integrated fibroblasts at the air-medium interphase, HaCaT cells are able to form a stratified and well-differentiated epidermis-like epithelium within 4 weeks (Schoop et al., 1999; Cerezo et al., 2003) . Accordingly, after 14 days of cultivation, both vector-transfected control cells had formed an only poorly stratified (mostly only three cell layers) epithelium, whereas after 4 weeks, the epidermis-like epithelium was fully differentiated and consisted of distinct basal, spinous and granular, as well as parakeratotic cornified layers. Figure 5a shows hematoxylin/eosinstained sections from 2-and 4-week-old OTCs from one of the two Hneo clones. Different from the control cells, the epithelia formed by the Hcyclin clones showed distinct changes (see Figure 5a ). After 2 weeks, all (6) 12 (2) Abbreviations: KAs, keratoacanthomas; SCCs, squamous cell carcinomas.
Figure 3 Cyclin D1 is constitutively overexpressed in Hcyclin keratinocytes. Protein lysates from subconfluent (s) and confluent (c) cultures from cyclin D1-transfected HaCaT cells (clones 6, 13 and 15) and two vector control clones (Hneo 1 and 2) were analysed by Western blotting for the expression level of cyclin D1. HaCaT 401C cells with high expression levels (Boukamp et al., 1999) are used as controls.
Cyclin D1 overexpression in keratoacanthoma B Burnworth et al epithelia already consisted of four to six cell layers. This difference was also verified when determining the number of nuclei from at least five different areas and in parallel cultures (Figure 5b ). Whereas differences in stratification were less pronounced after 4 weeks ( Figure  5a and b) , particularly when considering the number of layers present in the stratum corneum of the Hneo epithelia, the morphology of the Hcyclin epithelia differed significantly. They appeared undifferentiated, lacking morphologically distinct cell layers and signs of cornification.
Proliferation is increased during the initial growth of the Hcyclin clones in organotypic co-cultures To determine more precisely the changes in growth of the Hcyclin cells, 1-, 2-and 4-week-old OTCs were labeled with BrdU for 6 h before fixation and the BrdUlabeled cells were visualized by immunofluorescence. Evaluation of the BrdU labeling index demonstrated a proliferation rate of 10-15% for the Hneo control clones during the first 2 weeks, going back to B7% after 4 weeks in the fully differentiated epidermis (Figure 6a and data not shown). In the Hcyclin clones 6 and 15, proliferation was increased during the first week by about 20%. In clone 15 OTCs, proliferation also remained high at week 2, but decreased to control levels (B7%) at week 4, similar to that of clone 6 cultures ( Figure 6a ). Only clone 13 cells behaved differently (Figure 6a ). During the first week, the proliferation index was more similar to that of the Hneo control cells with only 10-15% of BrdU-labeled cells. However. different from all other cell types, proliferation remained rather constant throughout the 4 weeks arguing for a less dermis-dependent but more autonomous growth also in OTCs.
Even more than the number, the distribution of proliferating cells differed significantly in epithelia from Hcyclin versus Hneo control cells (Figure 6b , 2004) . Accordingly, in epithelia of both vector control clones, BrdU-positive nuclei were only seen in the basal layer ( Figure 6b and data not shown). In the epithelia of the Hcyclin clones, on the other hand, BrdU-positive nuclei were detected throughout the epithelium. As shown in Figure 6b , this was already visible after 1 week but became most striking after 4 weeks, demonstrating that it is not only the proliferation per se that is altered but the organization of proliferation within the tissue.
Differentiation is impaired in cyclin D1-overexpressing cells
To further evaluate the degree of disturbance, we next analysed how cyclin D1 overexpression affects keratinocyte differentiation. Sections of 1-, 2-and 4-week-old cultures were stained with antibodies against the basement membrane component type IV collagen (coll IV) as well as characteristic early (keratin K1/10 and involucrin) and late (filaggrin and loricrin) epidermal differentiation markers. As demonstrated in Figure 7 for 4-week-old cultures, Hneo control cells exhibited a similar distribution of differentiation markers as described previously for the parental HaCaT cells (Cerezo et al., 2003) . Keratin 1 and 10 were expressed in all suprabasal layers (Figure 7a ), the honeycomb-like involucrin staining started in the second suprabasal layer (Figure 7b ) and filaggrin was present in the uppermost living cell layer (Figure 7c ). Coll IV stained the boundary between the epithelium and the underlying dermal equivalent clearly marking the basement membrane zone.
With the exception of clone 15 OTCs, the basement membrane component coll IV was regularly localized in all cultures already after 1 week (data not shown). Clone 15 only showed coll IV after 4 weeks and even then the level was low (Figure 7a and c) . Keratins K1 and K10 were expressed by all Hcyclin cells but deposition was aberrant. Clone 6 epithelia only showed a few individual positive cells in the suprabasal layers, clone 15 epithelia expressed K1 and K10 only in the uppermost suprabasal layers, and in epithelia from clone 13 cells, positive cells were scattered throughout the epithelia (Figure 7a) . Involucrin was present in clone 6 and 15 cultures throughout the entire epithelium, although in a rather patchy distribution, whereas a largely normal suprabasal localization was characteristic for clone 13 OTCs (Figure 7b ). The two late differentiation markers filaggrin and loricrin (Figure 7c and data not shown) appeared as a spot-like pattern in the upper third of the epithelium of clone 6 epithelia. In clone 15 OTCs, both proteins were found throughout the entire epithelium, whereas in clone 13 epithelia, both proteins were absent.
To determine how these changes were related to overexpression of cyclin D1, we investigated the expression of the protein in the OTCs. As demonstrated for 4-weekold epithelia from one Hneo control clone and clone 13, as a representative of the Hcyclin clones, cyclin D1 protein was undetectable in the controls but staining was prominent throughout the entire epithelium of the cyclin D1-transfected cells (Figure 7d ). This clearly excluded alterations in cyclin D1 expression during in vivo growth.
Taken together, overexpression of cyclin D1 affects both proliferation and differentiation of the keratinocytes when grown in OTCs. It provides the cells with a slight growth advantage but it also alters differentiation. This does not necessarily result in blocking the expression of differentiation markers but obviously disturbed the balance crucial for an orderly sequence of epidermal differentiation. Despite these changes, the cells, with the exception of clone 13, remained responsive to fibroblastderived growth regulation, that is, inhibition of proliferation after 4 weeks.
Clone 13 cells form tumors after subcutaneous injection in nude mice
To determine whether epithelial disorganization is sufficient to drive tumor formation, we next injected the cells subcutaneously into nude mice and measured tumor growth at weekly intervals for 6 months. As expected, the vector-transfected Hneo cells remained non-tumorigenic. After a short growth phase, the nodules regressed completely (Figure 8a) . Similarly, none of the clone 6 injection sites developed tumors within the six months observation period (Figure 8b) . One tumor arose after injection of clone 15 cells (Figure 8c ). As this tumor only started to grow very late (>5 months after injection), additional genetic changes may have occurred during the long latency period in vivo. This tumor proved to be a small highly differentiated SCC (Figure 8e) .
From the clone 13 cells, two tumors developed (Figure 8d ). These started to grow around day 60, showed a rapid growth for 3 and 10 weeks, respectively, and after a stationary phase of 3-4 weeks decreased in size -a growth profile strongly resembling that of KAs. Whereas one tumor decreased to 15 mm 3 , and stayed stationary until the end of the experiment, the size of the second tumor steadily decreased from a maximum of 65 mm 3 and was completely regressed after 6 months. Histological evaluation of the remaining tumor revealed a disorganized parakeratotic epithelium that was encapsulated on the lower site by epithelium and was close to being rejected (Figure 8f) . By morphology, a certain similarity with a human KA is suggested (compare Figure 8f and g ).
The cell cycle components cdk4, p16 INK4 and p21 cip are deregulated in Hcyclin clones As the in vitro and in vivo studies suggested that clone 13 cells exhibited the most severe phenotype without showing the highest level of cyclin D1 protein, a dosedependent effect was unlikely. Having said this, cyclin Figure 6 The rate and the organization of proliferation is abnormal. Cells from Hneo and Hcyclin clones 6, 15 and 13 were cultured in three-dimensional organotypic co-cultures for 1, 2 and 4 weeks, labeled with 5-bromo-2 0 deoxyuridine (BrdU) for 6 h before fixation and embedded in paraffin. Sections were stained with a BrdU antibody. (a) Quantitative evaluation of the ratio of BrdU-labeled nuclei versus all nuclei. (b) Representative immunofluorescence staining from one -(left panel) and one 4-week-old culture (right panel) labeled with a BrdU-specific antibody (red nuclei) and counterstained with DAPI (blue nuclei). Note that in Hneo cultures, proliferation is restricted to the basal layer, whereas in all Hcyclin clones, labeled cells are present throughout the epithelium. Bar ¼ 50 mm.
Cyclin D1 overexpression in keratoacanthoma B Burnworth et al D1 is mediating its function through binding its catalytic partners, for example, the cyclin-dependent kinase 4 (cdk4). The cyclin-cdk4 complex is negatively regulated by p16 INK4 in that p16 INK4 blocks cdk4 from phosphorylating the retinoblastoma protein (Serrano et al., 1993) . On the other hand, p21 cip , besides being an inhibitor of cyclin E/cdk2 in late G1 phase, is thought to be involved in the formation of an active cyclin D1/cdk4 complex (Hiyama et al., 1997) .
To determine the consequences of cyclin D1 overexpression on these regulatory partners, we performed Western blot analyses (Figure 9) . As these are the cells with the highest degree of growth autonomy, including some tumor growth, it is tempting to suggest that overexpression of cyclin D1 per se does contribute to skin carcinogenesis by disturbing tissue homeostasis. However, only in combination with concomitant upregulation of its complex partners cdk4 and p21 cip , cyclin D1 also gains some oncogenic potential.
Discussion
Despite the high morbidity rate and the increasing number of metastasis, the genetic knowledge of skin SCCs is still poor (reviewed in Ashton et al., 2003) . Furthermore, the data presented to date still lack identification of specific aberrations present in the majority of tumors, thus hampering efforts to identify common pathways for skin cancer development. Using KAs as a paradigm of early-stage skin carcinogenesis, that is, a stage still compatible with spontaneous regression, we here show that gain of chromosome 11q and in particular the chromosomal region of 11q13, encompassing the cyclin D1 locus, is a frequent event. Furthermore, overexpression of cyclin D1 protein was seen in 80% (25/31) of KAs, making cyclin D1 an important oncogene in skin cancer development. To gain insight into the underlying mechanism, we established cyclin D1-overexpressing HaCaT keratinocytes and demonstrate that this not only caused a slight increase in proliferation but also deregulation of tissue architecture with an altered localization of proliferation and impaired differentiation. Clone 13 cells, which in addition to cyclin D1 overexpression also showed upregulation of cdk4 and p21 cip , revealed the most 11q gain-cyclin D1 overexpression: an important aberration in skin cancer development Although this is the first report on the identification of gain of chromosome 11q13 in KAs, aberrations of this chromosome are already described for a number of other tumor entities (reviewed in Fu et al., 2004) . The first aberration was a chromosome 11 inversion in a subset of parathyroid adenomas, which identified cyclin D1 gene as the responsible oncogene (Motokura et al., 1991) . Mantle-cell lymphomas and a subset of multiple myeloma contain a characteristic translocation with breakpoints within 1-2 kb of cyclin D1. In a number of other tumors, including breast, head and neck as well as esophagus carcinomas, amplification of the chromosomal region of 11q13 was found, which in part resulted in homogeneously staining regions (reviewed in Arnold and Papanikolaou, 2005) . Using both CGH (for gross chromosomal changes) and FISH analyses (for the cyclin D1 locus), we found gain of large chromosomal regions as well as amplification of the 11q13/cyclin D1 locus without gross chromosomal gains, suggesting that in skin cancer different genetic events contribute to an increase in cyclin D1 gene copy number. Furthermore, as amplification of the 11q13 region was described previously for some skin SCCs (Utikal et al., 2005a) and skin SCC lines (Popp et al., 2000 (Popp et al., , 2002 , our present data not only support the importance of 11q13 gain for skin cancer but also point to an early aberration already relevant at a state still compatible with spontaneous regression. By protein staining we show that about 80% of all KAs overexpressed cyclin D1, arguing that, in addition to chromosomal gain and/or translocation as well as amplification of the gene, mechanisms such as transcriptional upregulation or post-transcriptional modification contribute to cyclin D1 overexpression. A similar relationship between cyclin D1 gene amplification and cyclin D1 protein expression was recently reported for skin SCCs (Utikal et al., 2005b) . The authors found strong cyclin D1 staining in tumors that did not exhibit 11q13 amplification. Accordingly, it was proposed earlier that in most cancer types, cyclin D1 overexpression results from induction by oncogenic signals (Hosokawa and Arnold, 1998) . Whether this also accounts for those skin tumors with inconspicuous genetics remains to be investigated.
Cyclin D1 overexpression alters proliferation
The activities of cyclin D1 functions that are believed to drive tumorigenesis were recently summarized (Ewen and Lamb, 2004) . Most prominently, cyclin D1 overexpression promotes proliferation by deregulating the cell cycle control machinery owing to hyper-phosphorylation of the retinoblastoma gene and consequently loss of restriction point control. Measuring different proliferation parameters, our study revealed a more rapid population doubling time and/or increased BrdU labeling index, thus confirming a slight increase in proliferation. However, autonomous growth as measured by the ability to grow at clonal density was only improved in clone 13 cells, the only ones that had additionally upregulated the cyclin-dependent kinase cdk4. This may suggest that causing unrestricted proliferation by nullifying the restriction point requires equal amounts of both overexpressed cyclin D1 and its catalytic partner cdk4. In addition, we also observed endogenous upregulation of the cyclin-dependent kinase inhibitor p21 cip . This is in good agreement with a previous study where cyclin D1 was regulated ectopically with tetracycline in NIH3T3 cells and U343 human glioma cells and where ectopic expression of cyclin D1 was accompanied by increased levels of p21 cip (Hiyama et al., 1997) . In melanomas, the most devastating skin tumor, not only cyclin D1 amplification (Utikal et al., 2005b) but also germline or somatic mutations in the cdk4 gene were found. The latter are known to abrogate binding of p16
INK4A to cdk4 and with that to abrogate its growth inhibitory function (reviewed in Boukamp, 2005) . Thus, several mechanisms seem to target the same pathway, which causes an altered growth regulation.
In OTC -that is, under in vivo-like conditions -we observed an initially increased proliferation in clones 6 and 15 as compared to the vector control cells or the parental HaCaT cells. However, this enhanced growth was only temporary. After 4 weeks, proliferation had dropped to the same low level as in the control cultures. This strongly suggests that the growth-promoting effect induced in the HaCaT keratinocytes by overexpressing cyclin D1 could still be overcome by the environment, that is, the cells still remained sensitive to fibroblastderived signals controlling proliferation. Only clone 13 cells behaved differently. These cells showed an increased colony-forming efficiency in culture as well as a largely unaltered proliferation rate also in 4-week-old OTCs. Thus, clone 13 cells had obviously gained a higher degree of growth autonomy than clones 6 and 15 cells. This was also supported by the fact that in two injection sites tumors developed. As clone 13 cells are the only ones that concomitantly upregulated cdk4 and p21 cip , it is tempting to assume that the increase in growth autonomy was due to a more quantitatively balanced interaction of cyclin D1 with its complex partners rather than by cyclin D1 overexpression itself.
The tumors formed by clone 13 cells showed rapid increase followed by a stationary phase and final regression. This growth behavior, which largely reflects human KAs, may indicate that we indeed identified a genetic alteration responsible for this tumor stage. In agreement with this, it also shows that overexpression of the cyclin D1-dependent complex is not sufficient to fully overcome growth restrictions induced by the environment. Thus, this change is a prerequisite but not sufficient to transform cells to frank carcinoma cells.
Cyclin D1 overexpression disturbs tissue organization Changes in proliferation are not the only consequences of cyclin D1 overexpression. Actually, increased cyclin D1 levels did not always correlate with increased proliferation as measured by in situ staining for Ki67 of breast cancers (Oyama et al., 1998; Shoker et al., 2001) . Accordingly, cyclin D1 transgenic mice showed almost no alterations in their proliferation capacity. As a consequence thereof, cyclin D1 alternative functions were proposed (for review see Lesage et al., 2005) . We now demonstrate that all cyclin D1 overexpressing clones exhibited an abnormal tissue organization. This was characterized by a random distribution of proliferating cells in the epithelium as well as an aberrant or impaired expression of differentiation when analysed in organotypic co-cultures. Although all HaCaT-cyclin clones were still able to stratify, detailed analysis of the differentiation process demonstrated deregulation of the well-ordered sequential expression particularly of the late differentiation markers. This phenotype was unexpected because it was observed neither in vectortransfected control cells used in this or previous studies nor after transfection with other oncogenes including Ha-ras or c-myc (Boukamp et al., 1990; Cerezo et al., 2003; Rotzer et al., 2006) . This strongly excludes clonal variation of the HaCaT population as being causal for this phenotype, but suggests a very specific and novel role of cyclin D1 in this process.
Intriguingly, Hcyclin clone 13 cells that had additionally upregulated cdk4 and p21 cip lacked expression of the late epidermal differentiation markers. As it was proposed earlier that forced expression of p21 cip in mouse keratinocytes inhibited expression of markers of terminal differentiation (Di Cunto et al., 1998) , the most severe phenotype of the clone 13 cells may well be the result of a combined action of cyclin D1, cdk4 and p21 cip . Thus, our data confirm that in human keratinocytes also, increased p21 cip is correlated with halted terminal differentiation.
The transcription factor C/EBPb was shown to participate in the transcriptional regulation of cyclin D1 (reviewed in Ewen and Lamb, 2004) . Furthermore, deregulated expression of C/EBPb has been implicated in breast cancer (Zahnow, 2002) . It was also suggested that overexpressed cyclin D1 perturbs the differentiation-specific transcriptional programs exerted by C/ EBPb and that this contributes to its oncogenic actions. It is now of interest to investigate whether overexpression of cyclin D1 contributes to skin carcinogenesis by deregulating C/EBPb expression.
In summary, the present study provides strong evidence that 11q gain and/or cyclin D1 gene amplification, in addition to an as yet unidentified mechanism of cyclin D1 protein upregulation, cause overexpression in a high number of KAs. Thus, cyclin D1 overexpression is likely to be an important step in KA development. Although cyclin D1 is thought to be an oncogene, there is still considerable uncertainty about the precise downstream cellular mechanism by which it leads to neoplasia in vivo (Arnold and Papanikolaou, 2005) . Consistent with its well-recognized role in cell cycle control, a functional consequence of cyclin D1 overexpression in HaCaT skin keratinocytes was a slight improvement in growth. However, even more obvious was an abnormal tissue organization with irregular localization of the proliferation and impaired differentiation. Thus, one major function of cyclin D1 overexpression may be to interfere with the tightly regulated events required for an ordered sequence of proliferation and differentiation. As disturbing tissue homeostasis is not restricted to skin tumors, it remains to be seen whether cyclin D1 overexpression is interfering with tissue organization also in other tissue types. If so, it would not be surprising that cyclin D1 is not only overexpressed in a high number of KAs and skin SCCs (as shown here; see also Utikal et al., 2005a) but also in a substantial proportion of different human tumors (reviewed in Fu et al., 2004) . As our data further suggest that HaCaT cells gained tumorigenic potential only in cooperation with endogenous upregulation of cdk4 and p21 cip , high levels of cyclin D1 are obviously essential but not sufficient for tumorigenic conversion. It, therefore, will be of future interest to determine the role of cdk4 INK4A and/or p21 cip in skin cancer development.
Materials and methods

Comparative genomic hybridization
Reference DNA from peripheral blood was prepared according to standard protocols. Sections from 24 KAs, 16 formalinfixed, paraffin-embedded and eight frozen samples, were available. From these, 16 were derived from individual patients and were marked as sporadic, whereas eight were obtained from the same patient and marked as multiple (Table 1) . As there are no sufficiently reliable criteria to distinguish between KAs and SCCs of KA type, presence of the latter cannot be excluded. For paraffin-embedded sections, areas containing representative tumor tissue with more than 50% tumor cells were dissected from serial sections (50-100 mm) and collected in Eppendorf tubes. The tissue was deparaffinized for 3 Â 10 min in xylene (451C) and for 3 Â 5 min in ethanol, incubated overnight in 1 M sodium thiocyanate (371C), washed twice in DNA isolation buffer (75 mM NaCl, 25 mM EDTA, 0.5% Tween 20) and digested overnight with 1 mg/ml proteinase K (551C) and for 1 h with 200 mg/ml RNase A (371C). DNA was extracted by phenol/chloroform, precipitated with ethanol, and further purified by using the QIAEX II protocol (Qiagen, Hilden, Germany). Sections from frozen samples were directly digested and then treated accordingly.
Comparative genomic hybridization analysis, image acquisition and processing were performed as described previously (Boukamp et al., 1997) .
Fluorescence in situ hybridization Formalin-fixed paraffin-embedded tumor sections (5 mm) from 14 KAs and 11 SCCs were deparaffinized in xylene, dehydrated in 100% Ethanol and pretreated with the Vysis paraffin pretreatment kit (Vysis Inc., Downers Grove, IL, USA) using a slightly modified protocol: protease treatment was extended to 20 min and depending on the condition of the tumor material, specimens were not fixed (10% formalin) at the end of the pretreatment. Following denaturing of the probes (4 min, 781C), tumors were hybridized simultaneously with a directly labeled dual color probe, LSI Cyclin D1 (for the 11q13 region) Spectrum Orange/CEP 11 (for centromere 11) Spectrum Green (Vysis) for 24 h at 421C, washed in 1.5 M urea/ 0.1 Â SSC (30 min, 451C), 0.3% NP-40/0.5 Â SSC (10 min, 651C) and 2 Â SSC (2 min). Slides were mounted in anti-fade solution containing 4,6-diamidino-2-phenylindole (DAPI) to counterstain DNA (Vectashield, Vector Laboratories, Peterborough, UK) and analysed using an epifluorescence microscope (DMRA Fluorescence Microscope, Leica Microsystems AG, Wetzlar, Germany). Fluorescence in situ hybridization signals were counted in an average of 70 nonoverlapping nuclei, showing two hybridization signals for centromere 11.
Immunohistochemistry
Paraffin sections (5 mm) of normal skin, five actinic keratosis, 31 KAs and 17 SCCs were deparaffinized in 100% xylene and re-hydrated in a descending ethanol series according to standard protocols. Heat-induced epitope retrieval was performed in 10 mM citrate buffer at 951C for 40 min. Endogenous peroxidase activity was blocked with peroxidase blocking reagent containing 3% hydrogen peroxide (Dakocytomation GmbH, Hamburg, Germany) followed by incubation with a cyclin D1 antibody (1:5, Sigma-Aldrich Chemie GmbH Mu¨nchen, Germany) for 30 min at room temperature (RT). After washing, the sections were exposed to dextran polymer conjugated with horseradish peroxidase (Dakocytomation GmbH, Hamburg, Germany) and the peroxidase reaction was developed with 3,3-diaminobenzidine chromogen solution in DAB buffer substrate (Dako). Sections were counterstained with hematoxylin, mounted in Permaflour (Immunotech Inc. Westbrook, ME, USA) and analysed using a bright field microscope (AX-70, Olympus Microscopy, Hamburg, Germany).
Indirect immunofluorescence
Frozen sections were fixed in acetone (À201C, 10 min) followed by re-hydration in phosphate-buffered saline (PBS). After blocking in 3% bovine serum albumin/ PBS, the slides were incubated for 1.5 h at RT with antibodies against collagen type IV (1:200, Heyl, Chemisch -Pharmazeutische Fabrik GmbH and Co. KG, Berlin, Germany), filaggrin (1:200, Cell Systems Biotechnology, Remagen, Germany), involucrin (1:100, Sigma-Aldrich Chemie GmbH, Mu¨nchen, Germany), keratin 1/10 (1:200, Sigma) and loricrin (1:6, kindly provided by D Hohl, Lausanne). After washing, the sections were incubated with a red or green fluorochrome-conjugated secondary antibody (Alexa green-conjugated anti-mouse (1:800, Molecular Probes, Eugene, OR, USA), Cy2-conjugated anti-rabbit (1:100) and Cy3-conjugated anti-mouse (1:1000) or rabbit (1:1000), (all Dianova GmbH Immunodiagnostics, Hamburg, Germany) for 45 min at RT. For BrdU detection, acetone-fixed frozen sections were treated with 2 M HCl for 7 min, washed, blocked in 3% BSA and incubated in the presence of a fluorochromeconjugated anti-BrdU antibody (undiluted, ProGen Biotechnik GmbH, Heidelberg, Germany) (1 h at RT). The DNA was counterstained with 2 mg per ml bisbenzimid (Aventis Pharma, Bad Soden, Germany), sections washed in PBS, air dried and mounted in Permafluor. Analysis was performed using a DMRA epifluorescence microscope (LEICA Microsystems AG, Wetzlar, Germany) applied with appropriate filter sets, a CCD camera and image-acquisition software.
Cell culture, cell transfection and organotypic co-cultures HaCaT cells and respective clones were routinely cultured as described (Boukamp et al., 1988) . HaCaT cells were stably transfected in three independent experiments with the pRC/ CMV vector containing the human cyclin D1 cDNA (kindly provided by M Serrano, Madrid) using Genejammer Transfection Reagent (Stratagene, La Jolla, CA, USA). Hcyclin and Hneo (vector control) clones were selected for their ability to grow in the presence of 800 mg G-418 (PAA Laboratories GmbH, Pasching, Austria) per ml and maintained in culture medium supplemented with 400 mg G-418 per ml. Two independent experiments of organotypic co-cultures from Hneo and Hcyclin cells were prepared as described previously (Schoop et al., 1999) . The medium was changed every 2-3 days. The samples (duplicates from 1, 2 and 4 weeks) were cut in half and either fixed in 3.7% formaldehyde and prepared for routine histology or deep frozen. To study proliferation, BrdU was added 6 h before fixation of the cultures. The tissue sections were prepared according to standard protocols.
Proliferation and colony-forming efficiency studies Growth curves were performed by seeding 1.5 Â 10 4 cells per 60 mm dish in triplicate. The cells were trypsinized and counted (CASY cell counter, CASY GmbH, Reutlingen, Germany) every 24 h.
For BrdU incorporation analysis in vitro, 10 5 cells were seeded on microscope slides. After 24 h, the medium was changed, and after additional 24 h, the cells were incubated for 2.5 h in the presence of 65 mM BrdU in 0.9% NaCl (ICN Biochemicals Inc., Irvine, CA, USA). Immunofluorescence detection of BrdU was performed. The proliferation index represents the ratio of labeled versus total cell number.
To determine the colony-forming efficiency, triplicates of 500 cells were seeded in 10 cm plates. After 2 weeks, the cells were fixed with ethanol and colonies were stained with Mayer's hemalaun (Merck, Darmstadt, Germany) for 2 h and subsequently washed in water.
Tumorigenicity test 5 Â 10 6 cells in 100 ml were injected subcutaneously into each side of the back of four thymus-aplastic nude mice (Swiss/c nu/ nu backcrosses). Tumor growth was measured in weekly intervals for 6 months and tumor size was calculated in mm
